QuidelOrtho

QuidelOrtho is a global diagnostics company focused on developing and manufacturing technologies for diagnostic testing. Its work spans several technical domains, including immunoassay testing, molecular testing, point-of-care diagnostics, clinical lab diagnostics, and transfusion medicine. The company operates across healthcare, clinical laboratory, and point-of-care settings worldwide.

The company's history includes notable product milestones. It pioneered one of the earliest lateral-flow pregnancy test strips and developed the first FDA-approved rapid antigen diagnostic test for Influenza. More recently, it produced one of the earliest molecular PCR assays for SARS-CoV-2. This portfolio reflects a collective experience of more than 120 years in the diagnostics field.